MedPath

Assessing the impact of a self-guided digital intervention for fear of cancer recurrence (iConquerFear) in ovarian cancer survivors

Not Applicable
Conditions
Fear of cancer recurrence
Fear of progression
Depression
Ovarian cancer
Cancer - Ovarian and primary peritoneal
Mental Health - Depression
Mental Health - Other mental health disorders
Registration Number
ACTRN12622000592741
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

The study will include those who:
a)Are 18 years of age or older,
b)were diagnosed with early (stages I-II) or locally-advanced ovarian cancer (stage III),
c)have completed hospital-based treatment (surgery, radiotherapy or chemotherapy),
d)are able to provide informed consent to participate in research,
e)are proficient in English (i.e. able to read, write and speak English),
f)have low to moderate levels of depression (PHQ-9 scores equal or more than 20) and no suicidal ideation (equal to 0 on the PHQ-9 item-9)
g)have an email address and regular access to the internet, and
h)have an electronic device such as a PC, laptop, tablet or smartphone.

Exclusion Criteria

The study will exclude those who:
a)Are 17 years or younger,
b)are not able to provide informed consent to participate in research,
c)are not English proficient (able to read, write and speak English),
d)have not had a diagnosis of ovarian cancer,
e)have been diagnosed with stage IV ovarian cancer,
f)have not completed initial treatment yet,
g)are diagnosed with an ovarian cancer recurrence during the study,
h)have severe levels of depression (PHQ-9 equal to or less than 19) or suicidal ideation (greater than or equal to 1 on PHQ-9 item-9)
i)do not have an email address and regular access to the internet, and
j)do not have an electronic device such as a PC, laptop, iPad or smartphone.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath